Javascript is disabled in your browser. Please enable Javascript to view PeerJ.

September 2020

Table of Contents - PeerJ (Medicine Articles)

September 18, 2020

Potential COVID-19 papain-like protease PL^pro inhibitors: repurposing FDA-approved drugs

Valentina L. Kouznetsova, Aidan Zhang, Mahidhar Tatineni, Mark A. Miller, Igor F. Tsigelny

https://doi.org/10.7717/peerj.9965 PubMed 32999768

September 24, 2020

Characterization of a high-resolution breath acetone meter for ketosis monitoring

Donald J. Suntrup III, Timothy V. Ratto, Matt Ratto, James P. McCarter

https://doi.org/10.7717/peerj.9969 PubMed 33024634

September 22, 2020

Flavoured water consumption alters pharmacokinetic parameters and increases exposure of erlotinib and gefitinib in a preclinical study using Wistar rats

Aliyah Almomen, Hadir M. Maher, Nourah Z. Alzoman, Shereen M. Shehata, Amal Alsubaie

https://doi.org/10.7717/peerj.9881 PubMed 33024629

September 24, 2020

Saururus chinensis-controlled allergic pulmonary disease through NF-κB/COX-2 and PGE₂ pathways

MiKyung Song, Soon-Young Lee, Minhee Kim, Sangwoug Park, Juyeon Park, Yongbum Kwon, Dae-Hun Park

https://doi.org/10.7717/peerj.10043 PubMed 33024647

September 10, 2020

Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study

Hui-Ching Wang, Pei-Lin Liu, Pei-Chuan Lo, Yi-Tzu Chang, Leong-Perng Chan, Tsung-Jang Yeh, Hui-Hua Hsiao, Shih-Feng Cho

https://doi.org/10.7717/peerj.9862 PubMed 32974098

September 15, 2020

Proanthocyanidins reduce cellular function in the most globally diagnosed cancers in vitro

Sarah Albogami

https://doi.org/10.7717/peerj.9910 PubMed 32983646

← Previous
1
Next →